Taiwan FDA 結果共43筆

Taiwan’s FDA flagged imported products, including Tomax bay leaves, for pesticide violations. The 3,200-kg batch from Turkey must be returned or destroyed.

Taiwan’s FDA proposes classifying 2-Mercapto Etomidate as a Schedule 4 drug to combat ＂Zombie Vape＂ harm. Noncompliance may lead to fines up to NT$300,000.

ScinoPharm Taiwan secures U.S. FDA approval for Glatiramer Acetate Injection, marking a first for Taiwan. Sales begin in Q2 2026, boosting revenue and global reach.

Samsung Electronics has launched a sleep apnea detection feature on its Health Monitor app in Taiwan. Approved by the Taiwan FDA, it aids users 22 and older in identifying potential risks.

Taiwan’s Ministry of Health and Welfare announced that 47 drugs had withdrawal plans by September 2025. Most have substitutes, but one organ transplant drug will cease production.

Taiwan will lift strict food import rules from five Japanese prefectures, including Fukushima, by year’s end. The change follows international standards and public feedback.

Quanta Computer partners with Taiwan’s Ministry of National Defense to develop an electronic injury ticket system, enhancing military healthcare with smart tech.

Taiwan’s FDA reports eight product batches failed border inspections, with U.S. oysters and avocados exceeding cadmium limits. Increased inspections are planned.

Taiwan’s FDA investigates Adimmune Corp. for potential GMP violations after a lab incident. Concerns rise over vaccine safety, but officials assure thorough testing.

The Consumers’ Foundation Chinese Taipei opposes Taiwan FDA’s plan to lift age restrictions on Japanese beef imports, citing mad cow disease risks and urging transparency.

Health Minister Chiu Tai-yuan plans a meeting to discuss reclassifying emergency contraceptive pills as pharmacy-dispensed drugs. The FDA and MOE will join talks.

Taiwan’s FDA announced that cinnamon powder, Korean cookie sticks, and Japanese curry powder failed safety tests. These imports will be returned or destroyed.

Taiwan’s FDA fined all-you-can-eat restaurants NT$240,000 for hygiene violations. Seven beverages and ice products failed standards. Notable names include Lakeshore Hotel and Chiba Hot Pot.

Taiwan’s Ministry of Health and Welfare warns against illegal Chinese ＂wax candy＂ in local markets, citing unknown ingredients and health risks. Consumers should verify product sources.

Discover the latest on the recall of 360 boxes of Alcon contact lenses in Taiwan due to quality issues, affecting two products and aimed to be completed by Sept. 13. Learn about the safety measures and consumer advice.

Discover why Taiwan’s FDA announced the phased exit of Aprovel and Prozac from the market starting in November, and how it plans to ensure uninterrupted patient care with alternative medications.

Discover the latest on food safety: Taiwan’s FDA found excessive mycotoxins in peanut powder and red yeast rice, posing health risks. Learn more about the actions taken and health implications.

Discover the latest on Taiwan’s COVID-19 vaccine strategy as the CDC plans to select a variant for the fall vaccination campaign amid rising cases and new FDA recommendations.

Discover how Taiwan is addressing its intravenous fluid shortage, with hospitals halting surgeries and the MOHW promising supply improvements by July. Learn about the impact of Y F Chemical Corp’s production halt and the efforts to stabilize the situation.

Discover how Taiwan is tackling its saline solution shortage with the arrival of 100,000 bottles on June 12 and steps taken by the FDA to ensure medical supply continuity.

Discover why Taiwan’s FDA is destroying three U.S.-imported seasoning sauces, including a popular steak sauce, due to carcinogen ethylene oxide detection. Learn more about the safety measures.

Discover why Taiwan’s FDA is destroying three U.S.-imported seasoning sauces, including a popular steak sauce, due to carcinogen ethylene oxide detection. Learn more about the safety measures.

Taiwan’s FDA announces a recall of Otsuka America Pharmaceutical’s ABILIFY tablets due to contamination concerns after a notification from the U.S. FDA. The recall affects 1.789 million tablets of 5mg and 30mg doses across three batch numbers, used for treating schizophrenia and other disorders, after unclean production lines led to potential mixing with other pharmaceutical ingredients. The Taiwan FDA urges completion of the recall by May 26 and advises patients to seek alternative treatments.

Explore the ongoing controversy in Taiwan over Kobayashi Pharmaceutical’s red yeast product, as the FDA investigates 58 cases of adverse reactions without confirmed causality, amidst reports of kidney disease and deaths in Japan. Taiwan responds with preventive recalls and consumer protection measures.

Taipei (TVBS News) reports that Taiwan’s Food and Drug Administration (FDA) has taken action after businesses reported using red yeast rice raw materials from Japan’s Kobayashi Pharmaceutical, linked to kidney disease. Preventive measures have been taken, with products removed from shelves. FDA Director-General Wu Hsiu-mei oversees the situation to safeguard consumer safety.